The CDC has released its survey data on how many Americans are getting the recommended cancer screening test for cervical, breast and colorectal cancer. They believe too few are following their advice. We think the issue is more nuanced.
Each year, about three million women in the United States will have an suspicious or abnormal pap test, according to the CDC. Following the abnormal results, women often undergo diagnostic testing a colposcopy or biopsy and if precancerous lesions are
A new study conducted by the National Institutes of health s National Cancer Institute has found that negative tests for the human papillomavirus virus (HPV) are more reliable in predicting
As we reported last month, an advisory panel to the FDA recommended that the agency approve a new test for human papillomavirus (HPV) for screening women for cervical cancer. The new test could potentially replace the current Pap test that has been in use for decades.
Millions of women worldwide have been tested for cervical cancer, human papillomavirus (HPV) and other problems via the PAP test. The procedure was invented in 1943 by Dr. George Papanicolaou (thus the name), and has become the most widely used cancer-screening test in the world
Two pieces of good news regarding protecting from, and detecting early, cervical cancer caused by HPV: one dose of vaccine may work as well as the recommended three; and screening cervical cells for HPV may be more predictive of dangerous infection than the Pap smear.